ReviewCurrent cardiology reports2025
Current Status of Cardiovascular Disease in Asian Americans: One Size Does Not Fit All.
Review in Current cardiology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewTo provide an updated summary of knowledge about cardiovascular disease in Asian Americans living in the United States. RECENT
findingsAsian Americans living in the United States are a heterogenous and diverse group of individuals with variable coronary artery disease, heart failure, and stroke prevalence and risks and mortality rates. Compared to other Asian American subgroups, East Asians tend to have lower coronary artery disease risks, South Asians have high prevalence of traditional cardiovascular risks, particularly diabetes, and Southeast Asians have high rates of hypertension and age-adjusted stroke mortality death rate. Multiple studies have demonstrated disparities among various Asian Americans subgroups in cardiovascular disease, heart failure, and stroke risk. Valvular heart disease, arrhythmia, pharmacotherapy treatment, and procedural outcome data are limited. It is important to report disaggregated and sex-specific data in future clinical trials not only for racial groups but also for Asian American ethnic subgroups.
Indexed as
Identifiers
40528042What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.